Chapter 1: Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2: Market Overview
- Bulk vs. Single-Cell Sequencing
- PESTLE Analysis
- Porter’s Five Forces Analysis
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Potential of New Entrants
- Competition in the Industry
- Threat of Substitutes
Chapter 3: Market Dynamics
- Market Drivers
- Rising Incidence of Cancer
- Growing Demand for Personalized Medicine
- Increasing Investment and Funding
- Market Restraints
- High Cost of Single-Cell Analysis
- Market Opportunities
- Market Challenges
- Complexity of Single-Cell Sequencing
Chapter 4: Emerging Technologies and Developments
- Emerging Technologies
- Advances in Bioinformatics
- Microfluidics
- Artificial Intelligence
- Clinical Trials Analysis
- Clinical Trials Analysis, by Type of Study
- Clinical Trials Analysis, by Status
- Clinical Trials Analysis, by Phase
- Selected Clinical Trials
- Patent Analysis
- Patents by Year
- Patents by Top Applicants
- Patents by Top Owner
- Patents by Jurisdiction
Chapter 5: Market Segmentation Analysis
- Market Analysis by Product
- Market Breakdown by Cell Type
- Human Cells
- Animal Cells
- Microbial Cells
- Market Breakdown by Technique
- Flow Cytometry
- Next-Generation Sequencing
- Polymerase Chain Reaction
- Microscopy
- Mass Spectrometry
- Other Techniques
- Market Breakdown by Application
- Research Applications
- Medical Applications
- Market Breakdown by End User
- Research and Academic Laboratories
- Biotechnology and Pharmaceutical Companies
- Hospitals and Diagnostic Laboratories
- Cell Banks and IVF Centers
- Market Analysis by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 6: Competitive Intelligence
- Market Analysis
- Top Players
- Emerging Startups
- Strategic Analysis
Chapter 7: Sustainability in Single-cell Technologies: An ESG Perspective
- Introduction to ESG
- Sustainability in Single-Cell Technologies Industry: An ESG Perspective
- Key ESG Issues
- Single-Cell Technologies ESG Performance Analysis
- Concluding Remarks from BCC
List of Tables
Summary Table: Global Market for Single-Cell Technologies, by Product, Through 2029
Table 1: Clinical Trials in Single-Cell Technology, by Type of Study, as of June 2024
Table 2: Clinical Trials in Single-Cell Technology, by Status, as of June 2024
Table 3: Clinical Trials in Single-Cell Technology, by Phase, as of June 2024
Table 4: Select Clinical Trials in Single-Cell Technology
Table 5: Patents, by Top Applicants, 2020-2023
Table 6: Patents, by Top Owner, 2020-2023
Table 7: Patents, by Jurisdiction, 2020-2023
Table 8: Global Market for Single-Cell Technologies, by Product, Through 2029
Table 9: Assay Kits Offered by 10X Genomics
Table 10: Global Market for Single-Cell Technologies Consumables, by Region, Through 2029
Table 11: Single-Cell Technologies Flow Cytometry Systems, by Company
Table 12: Single-Cell Technologies NGS Systems, by Company
Table 13: Single-Cell Technologies PCR Systems, by Company
Table 14: Single-Cell Technologies Mass Spectrophotometers, by Company
Table 15: Single-Cell Technologies Microscopes, by Company
Table 16: Global Market for Single-Cell Technologies Instruments, by Region, Through 2029
Table 17: Global Market for Single-Cell Technologies, by Cell Type, Through 2029
Table 18: Global Market for Single-Cell Technologies in the Human Cells Segment, by Region, Through 2029
Table 19: Global Market for Single-Cell Technologies in the Animal Cells Segment, by Region, Through 2029
Table 20: Global Market for Single-Cell Technologies in the Microbial Cells Segment, by Region, Through 2029
Table 21: Global Market for Single-Cell Technologies, by Technique, Through 2029
Table 22: Global Market for Flow Cytometry in Single-Cell Technologies, by Region, Through 2029
Table 23: Global Market for Next-Generation Sequencing in Single-Cell Technologies, by Region, Through 2029
Table 24: Global Market for Polymerase Chain Reaction in Single-Cell Technologies, by Region, Through 2029
Table 25: Global Market for Microscopy in Single-Cell Technologies, by Region, Through 2029
Table 26: Global Market for Mass Spectrometry in Single-Cell Technologies, by Region, Through 2029
Table 27: Global Market for Other Techniques in Single-Cell Technologies, by Region, Through 2029
Table 28: Global Market for Single-Cell Technologies, by Application, Through 2029
Table 29: Global Market for Research Applications in Single-Cell Technologies, by Region, Through 2029
Table 30: Global Market for Medical Applications of Single-Cell Technologies, by Region, Through 2029
Table 31: Global Market for Single-Cell Technologies, by End User, Through 2029
Table 32: Global Market for Single-Cell Technologies in Research and Academic Laboratories, by Region, Through 2029
Table 33: Global Market for Single-Cell Technologies in Biotechnology and Pharmaceutical Companies, by Region, Through 2029
Table 34: Global Market for Single-Cell Technologies in Hospitals and Diagnostic Laboratories, by Region, Through 2029
Table 35: Stem Cell Banks and Registries Worldwide, by Country
Table 36: Global Market for Single-Cell Technologies in Cell Banks and IVF Centers, by Region, Through 2029
Table 37: Global Market for Single-Cell Technologies, by Region, Through 2029
Table 38: Single-Cell Technologies: Market Player Share Analysis, 2023
Table 39: Single-Cell Technologies Market: Recent Developments
Table 40: ESG Rankings for Single-Cell Technology Companies, 2024*
Table 41: ESG in Single-cell Technologies: Environmental Overview
Table 42: ESG in Single-Cell Technologies: Social Overview
Table 43: ESG in Single-cell Technologies: Governance Overview
Table 44: Report Sources
Table 45: Glossary of Terms Used in Single-Cell Technologies Market
Table 46: 10x Genomics: Company Snapshot
Table 47: 10x Genomics: Financial Performance, FY 2022 and 2023
Table 48: 10x Genomics: Product Portfolio
Table 49: 10x Genomics: News/Key Developments, 2021-2024
Table 50: Agilent Technologies Inc.: Company Snapshot
Table 51: Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 52: Agilent Technologies Inc.: Product Portfolio
Table 53: Agilent Technologies Inc.: News/Key Developments, 2021
Table 54: BD: Company Snapshot
Table 55: BD: Financial Performance, FY 2022 and 2023
Table 56: BD: Product Portfolio
Table 57: BD: News/Key Developments, 2023 and 2024
Table 58: Bio-Rad Laboratories Inc.: Company Snapshot
Table 59: Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 60: Bio-Rad Laboratories Inc.: Product Portfolio
Table 61: Danaher Corp.: Company Snapshot
Table 62: Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 63: Danaher Corp.: Product Portfolio
Table 64: Danaher Corp.: News/Key Developments, 2023 and 2024
Table 65: Illumina Inc.: Company Snapshot
Table 66: Illumina Inc.: Financial Performance, FY 2022 and 2023
Table 67: Illumina Inc.: Product Portfolio
Table 68: Merck KGaA: Company Snapshot
Table 69: Merck KGaA: Financial Performance, FY 2022 and 2023
Table 70: Merck KGaA: Product Portfolio
Table 71: Promega Corp.: Company Snapshot
Table 72: Promega Corp.: Product Portfolio
Table 73: Qiagen: Company Snapshot
Table 74: Qiagen: Financial Performance, FY 2022 and 2023
Table 75: Qiagen: Product Portfolio
Table 76: Qiagen: News/Key Developments, 2024
Table 77: Thermo Fisher Scientific Inc.: Company Snapshot
Table 78: Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 79: Thermo Fisher Scientific Inc.: Product Portfolio
Table 80: Thermo Fisher Scientific Inc.: News/Key Developments, 2021
List of Figures
Summary Figure: Global Market for Single-Cell Technologies, by Product, 2021-2029
Figure 1: Single-Cell Technologies: Overview
Figure 2: Single Cell Sequencing: Workflow
Figure 3: Comparison of Bulk Cell Sequencing vs. Single-cell Sequencing
Figure 4: Single-Cell Technologies: PESTLE Analysis
Figure 5: Market Dynamics of Single-Cell Technologies
Figure 6: Estimated Numbers of All Cancer Cases, Males and Females (0 to 85+ Years), 2022-2050
Figure 7: Personalized Medicine: Growing Share in Total New Molecular Entities (NMEs), 2019-2022
Figure 8: Percentage of Deaths from NCDs in Asia-Pacific Countries, 2019
Figure 9: Emerging Trends/Technologies in the Single-Cell Technology Market
Figure 10: Microfluidic Chip Technology: Principal Types
Figure 11: Patents Granted, by Year, 2020-2023
Figure 12: Global Market Shares of Single-Cell Technologies, by Product, 2023
Figure 13: Global Market Shares of Single-Cell Technologies, by Cell Type, 2023
Figure 14: Global Market Shares of Single-Cell Technologies, by Technique, 2023
Figure 15: Global Market Shares of Single-Cell Technologies, by Technique, 2023
Figure 16: Global Market Shares of Single-Cell Technologies, by Application, 2023
Figure 17: Global Market Shares of Single-Cell Technologies, by End User, 2023
Figure 18: Examples of Research and Academic Laboratories Utilizing Single-Cell Technologies
Figure 19: Global Market Shares of Single-Cell Technologies, by Region, 2023
Figure 20: U.S. NIH Funding for Genome Research, 2021-2023
Figure 21: North America Market for Single-Cell Technologies, 2021-2029
Figure 22: European Market for Single-Cell Technologies, 2021-2029
Figure 23: Asia-Pacific Market for Single-Cell Technologies, 2021-2029
Figure 24: Rest of the World Market for Single-Cell Technologies, 2021-2029
Figure 25: ESG Pillars
Figure 26: Advantages of ESG for Companies
Figure 27: Methodology Used in Single-Cell Technologies Market
Figure 28: 10x Genomics: Revenue Share, by Business Unit, FY 2023
Figure 29: 10x Genomics: Revenue Share, by Region, FY 2023
Figure 30: Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 31: Agilent Technologies Inc.: Revenue Share, by Region, FY 2023
Figure 32: BD: Revenue Share, by Business Unit, FY 2023
Figure 33: BD: Revenue Share, by Country/Region, FY 2023
Figure 34: Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 35: Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 36: Danaher Corp.: Market Share, by Business Unit, FY 2023
Figure 37: Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 38: Illumina Inc.: Revenue Share, by Business Unit, FY 2023
Figure 39: Illumina Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 40: Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 41: Merck KGaA: Revenue Shares, by Region, FY 2023
Figure 42: Qiagen: Market Share, by Business Unit, FY 2023
Figure 43: Qiagen: Revenue Share, by Region, FY 2023
Figure 44: Thermo Fisher Scientific Inc.: Market Share, by Business Unit, FY 2023
Figure 45: Thermo Fisher Scientific Inc.: Revenue Share, by Region, FY 2023
